My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2008-07-11_PERMIT FILE - M2007044 (6)
DRMS
>
Day Forward
>
Permit File
>
Minerals
>
M2007044
>
2008-07-11_PERMIT FILE - M2007044 (6)
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
8/24/2016 3:34:32 PM
Creation date
7/17/2008 8:14:31 AM
Metadata
Fields
Template:
DRMS Permit Index
Permit No
M2007044
IBM Index Class Name
PERMIT FILE
Doc Date
7/11/2008
Doc Name
Appendix H and I (volume 2)
From
Energy Fuels Resources Corp
To
DRMS
Email Name
GRM
Media Type
D
Archive
No
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
80
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
. Skin Contact: Remove contaminated clothing and <br />shoes immediately. Wash with soap or mild <br />detergent and large amounts of water until no <br />evidence of chemical remains (at least 15-2.0. <br />minutes..) <br />Eye Contact: Immediately flush the eyes with large <br />quantities of running water for a minimum of 15 <br />minutes. Hold the eyelids apart during the flushing <br />to ensure rinsing of the entire surface of the eye <br />and lids with water. Do not attempt to neutralize <br />with chemical agents. Obtain medical attention as <br />soon as; possible. Oils or ointments. should not he <br />used. Continue the flushing for an additional 15 <br />minutes If the physician is rot Immediately <br />available. <br />NOTE TO PHYSICIAN: <br />ANTIDOTE: <br />The following antidote has been recommended <br />However. the decision as to where the seventy of <br />poisoning requires administration of any antidote <br />and actual dose required should be made by <br />qualified medical personnel. <br />Iron-Salt Poisoning. Give deferoxamine, 15 <br />mg/kg hour by continuous intravenous infusion to a <br />maximum of 80 mg/kg In each 12 hour period. <br />Monitor the blood pressure during administration of <br />deferoxamine and reduce the rate of administration <br />if the blood pressure falls. Single doses should not <br />exceed 1 gram and the maximum to 24 hours <br />should not exceed 6 grams. Deferoxamine is <br />hazardous in patients with severe renal disease or <br />anuria, and dialysis is necessary. <br />Injected deferoxamine is associated with a high <br />risk and should be reserved for serious poisoning.. <br />Continue deferoxamine therapy until the patient is. <br />free of symptoms and signs for 24 hours. <br />IX:. REACTIVITY DATA <br />REACTIVITY: <br />Stable under normal temperatures and pressures. <br />CONDITIONS TO AVOID: <br />• <br />36
The URL can be used to link to this page
Your browser does not support the video tag.